Clifford Swan Investment Counsel LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Clifford Swan Investment Counsel LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 09, 2020	SELL	$20.56 - $63.12 $440,148 - $1.35 Million	-21,408 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$28.14 - $73.01 $64,722 - $167,923	2,300 Added 12.04%	21,408 $1.36 Million
Q2 2019 Aug 13, 2019	SELL	$17.43 - $28.82 $177,786 - $293,964	-10,200 Reduced 34.8%	19,108 $506,000
Q1 2019 May 14, 2019	SELL	$12.05 - $20.18 $498,966 - $835,613	-41,408 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $77,650 - $142,431	7,230 Added 21.15%	41,408 $514,000
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $478,492 - $693,813	34,178 New	34,178 $655,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.